NANEMIAR are participating in the European Hematology Association Congress (EHA 2026), one of the most important international scientific meetings in the field of hematology. Dr. Perez-Oliva was invited as a speaker in today's session, "Inflammasome in Congenital Anemias", where she delivered a presentation entitled "Inflammasome and Its Implicatio...
News & Events
In this new NANEMIAR interview, we spoke with Léa Girondier (CNRS), a researcher in the project, who shares her experience in the development of new therapeutic strategies for congenital anemias. Throughout the conversation, she explains her role in conducting experiments using ex vivo and in vivo models, the technical challenges involved in optimi...
The session featured the participation of Dr. Ana Belén Pérez Oliva, who presented the advances and possibilities offered by lipid nanoparticles for delivering gene therapies and therapeutic molecules directly to affected blood cells. This technology represents one of the most promising approaches within personalized medicine and nanotechnology app...
Science is once again leaving the laboratory to connect with the public in a different setting: bars. The international festival Pint of Science Spain brings together researchers and citizens for three days of science outreach events where research is explained in a close, accessible, and engaging way. The initiative was born in 2012 at Imperial Co...
Every May 8th, International Thalassemia Day is observed to raise awareness about this inherited genetic condition that affects hemoglobin production and can lead to chronic anemia. Prevention, early diagnosis, and education are essential tools to improve the quality of life of those affected. Knowing family medical history and undergoing timely me...